GOLD COPD 2017 Resource Center: Activity Seven: Comorbidities

Resource Center Title

GOLD COPD 2017 Resource Center:
Activity Seven

Activity Title

Comorbidities in COPD
David Halpin, MD

Click here to view this activity

Program Goals

This collaborative activity presented by the Global Initiative for Chronic Obstructive Lung Disease
(GOLD) and Temple University Lung Center is to provide attendees with an exceptional opportunity to learn, network, share knowledge and ideas, establish collaborative projects, and set priorities in the management strategy for Chronic Obstructive Lung Disease. This topic is one of 10 that were presented at the November 16, 2016 GOLD COPD Care Continuum in Philadelphia, PA.

In 2017, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) released the updated Global Strategy for the Diagnosis, Management, and Prevention of COPD. The revisions, presented in the management strategies for COPD are once again based on scientific literature published since the completion of the original documents and updates but maintain the same treatment paradigm. Participants in this activity have an opportunity to gain a better understanding of the current state this “strategy document” has for health care professionals to be able to use it as a highly useful tool in implementing elective management programs based on available health care systems.

Target Audience

The educational design of this activity addresses the needs of physicians, physician assistants, respiratory therapists, nurse practitioners, nurses, case managers, cardiopulmonary specialists and other healthcare practitioners involved in the diagnosis, treatment care of patients with COPD.

Learning Objectives

After completion of this activity, participants will be able to:
1. Describe causes of death in COPD.
2. Discuss the systemic effects and comorbidities in COPD.
3. Review the main comorbidities.

Faculty

CHAIRMAN

Gerard Criner, MD, FACP, FACCP
Professor of Medicine
Lewis Katz School of Medicine
Temple University School of Medicine
Chair, Department of Thoracic Medicine & Surgery
Co-Director Center for Inflammation and Lung Research
Medical Director of Pulmonary Service Line
Temple University Hospital
Philadelphia, PA

CONTRIBUTING FACULTY

Roberto Rodriguez-Roisin, MD, PhD
Professor Emeritus of Medicine
Universitat de Barcelona
Department of Pulmonary Diseases
Hospital Clinic Vilarroel
Barcelona, Spain

Claus Vogelmeier, MD
Professor of Internal Medicine
Head of Pulmonary and Critical Care Medicine
University Medical Center Giessen and Marburg
Philipps-University Marburg
Germany School of Medicine
Marburg, Germany

Nicolas Roche, MD, PhD
Professor of Respiratory Medicine,
Respiratory and Intensive Care Medicine
Cochin-Hôtel-Dieu-Broca Hospital Group
University of Paris Descartes
Assistance Publique- Hôpitaux
Paris, France

Fernando Martinez, MD
Executive Vice Chair of Medicine
Gladys and Roland Harriman Professor of Medicine
Joan and Sanford I. Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, NY

Antonio R. Anzueto, MD
Chief 0f Pulmonary Section
Medical Director of Pulmonary Function Laboratory, Respiratory Therapy Department and Bronchoscopy Laboratory
Director of Pulmonary Function Laboratory and Pulmonary Service Spinal Cord Unit
Staff Physician, South Texas Veterans Health Care System
Audie L. Murphy Memorial Veterans Hospital Division
Director of Pulmonary Function Laboratory
University Hospital
Adjunct Scientist, Southwest Foundation for Biomedical Research
Professor, University of Texas Health Science Center
San Antonio Department of Medicine
San Antonio, TX

David Michael George Halpin, MD
Consultant Physician
Royal Devon & Exeter Hospital
Honorary Associate Professor
University of Exeter Medical School
Devon, United Kingdom

Maria Victorina López Varela, MD
Chair, GOLD Dissemination Committee
Professor Agregado de Neumología
Universidad de la República
Montevideo, Uruguay

Alvar Agustí, MD, PhD
Associate Professor of Medicine
University of Barcelona
Director, Thorax Institute, Hospital Clinic
Barcelona, Spain

Educational Activity Agenda

Comorbidities in COPD

Front Matter and Registration (3 minutes)
Faculty Introduction, Presentations and Roundtable Discussions (54 minutes)
Post Test, Evaluation, and Credit Application (10 minutes)

Release and Expiration Dates

Enduring Archive Release Date: June 15, 2017
Enduring Archive Expiration Date: June 15, 2018

Disclosure of Conflicts of Interests

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Disclosure information will be provided to participants prior to the beginning of the educational activity.

Faculty Disclosures

The faculty reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Gerard J. Criner, MD

Grant/Research Support: NIH-NHLBI, PA-DOH,GSK, Boehringer- Ingelheim, Novartis, Astra Zeneca, Respironics, MedImmune, Actelion, Forest, Pharmaxis, Pearl, Ikaria, Aeris, PneumRx, Pulmonx
Honoraria: None
Consultation: Amirall, Holaira, Boehringer-Ingelheim, GSK, Pearl, Astra Zeneca, PneumRX
Equity Interest: HGE Health Care Solutions, Inc.

Roberto Rodriquez-Roisin, MD

Consultant: AstraZeneca, Boehringer Ingelheim, Ferrer, Menarini, Novartis, Pearl, Takeda and TEVA
Grant/Research Support: Almirall and Menarini

Claus Vogelmeier, MD

Grant/Consultant Support: AstraZeneca, CSL Behring, Berlin Chemie/Menarini, Boehringer Ingelheim, Cipla, GlaxoSmithKline, Grifols, MedUpdate, Mundipharma, Novartis, OmniaMed

Nicolas Roche, MD

Grant/Consultant Support: 3M, Almirall/AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Zambon, Mundipharma, Novartis, Nycomed/Takeda, Pfizer, Sandoz, Sanofi and Teva

Fernando Martinez, MD

Grant/Consultant Support: Adept, Academic CME, Afferent, American College of Chest Physicians, AstraZeneca, Bayer, Boehringer Ingelheim, Concert, Genentech, Gilead, GlaxoSmithKline, Integritas, Medical Leverage, Mereo, Methodist Hospital, Miller Medical, Novartis, PeerView, PlatformIQ, Potomac, Prime, ProterixBio, Stromedix/Biogen, Theravance, UpToDate, Veracyte, WebMD/MedScape, Western Connecticut Health Network

Antonia R. Anzueto, MD

Consultant: AstraZeneca, Novartis, Boehringer-Ingelheim, GSK, Sunovion

David Halpin, MD

Grant/Consultant Support: Almirall/AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Pfizer, Sandoz

Maria Victorina Lopez Varela, MD

Consultant: Astra Zeneca, Boehringer Ingelheim, Glaxo SmithKlein, Novartis.

Alvar Agusti, MD, PhD

Nothing to Disclose

Planners and Managers

The planners and managers reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

GLOBAL EDUCATION GROUP / GANESCO, INC.

Ashley Marostica, RN, MSN

Nothing to disclose

Kristen Delisi

Nothing to disclose

Lindsay Borvansky

Nothing to disclose

Laura Gilsdorf

Nothing to disclose

Gail Varcelotti, BS, RRT, FAARC, Ganesco, Inc.

Nothing to disclose

Nancy Nunley, BS, MBA, Ganésco, Inc

Nothing to disclose

CME Provided Accreditation Statement

This activity is provided by Global Education Group.

Physician Accreditation Statement - CME

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

*This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation - CME

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Education Group

For information about the physician accreditation for this activity, please contact Global Education Group at (303) 395-1782, or inquire@globaleducationgroup.com.

How to Obtain CME Credit

Attendees are expected to view the entire activity before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit™ or nursing credit. To receive credit, the course must be completed between June 15, 2017 and June 15, 2018.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive CME/CE credit for viewing the webcast:

Read all of the CME/CE accreditation information above.
View the complete electronic (web) activity.
Click on the link to apply for CME/CE credits.
Complete the online registration (registration is free).
Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity.

Should you have any CME/CE questions regarding this activity, please contact:

Global Education Group
5575 S. Sycamore Street, Suite 200 Littleton, CO 80120
Phone: 303-395-1782
Fax: 303-648-5311
Email: inquire@globaleducationgroup.com
Web: www.globaleducationgroup.com

Click here to view this activity

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

Global Education Group (Global) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Global Education Group and Dane Garvin, Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online.
“Comorbidities in COPD”

System Requirements

To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled. Nearly all modern web browsers will work.

Commercial Support Statement

This online Resource Center is supported by Educational Grants from AstraZeneca, GlaxoSmithKline, Boehringer Ingleheim, BTG International Inc. and PneumRx.

Copyright

Copyright^©2017 Global Initiative for Chronic Obstructive Lung Disease. All Rights Reserved. Permission for accreditation use granted to Global Education Group (Global). Web interface provided by Dane Garvin Ltd.


	Resource Center Title Click here to register for this event GOLD COPD 2017 Resource Center: Activity Seven Activity Title Comorbidities in COPD David Halpin, MD Click here to view this activity Program Goals This collaborative activity presented by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and Temple University Lung Center is to provide attendees with an exceptional opportunity to learn, network, share knowledge and ideas, establish collaborative projects, and set priorities in the management strategy for Chronic Obstructive Lung Disease. This topic is one of 10 that were presented at the November 16, 2016 GOLD COPD Care Continuum in Philadelphia, PA. In 2017, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) released the updated Global Strategy for the Diagnosis, Management, and Prevention of COPD. The revisions, presented in the management strategies for COPD are once again based on scientific literature published since the completion of the original documents and updates but maintain the same treatment paradigm. Participants in this activity have an opportunity to gain a better understanding of the current state this “strategy document” has for health care professionals to be able to use it as a highly useful tool in implementing elective management programs based on available health care systems. Target Audience The educational design of this activity addresses the needs of physicians, physician assistants, respiratory therapists, nurse practitioners, nurses, case managers, cardiopulmonary specialists and other healthcare practitioners involved in the diagnosis, treatment care of patients with COPD. Learning Objectives After completion of this activity, participants will be able to: 1. Describe causes of death in COPD. 2. Discuss the systemic effects and comorbidities in COPD. 3. Review the main comorbidities. Faculty CHAIRMAN Gerard Criner, MD, FACP, FACCP Professor of Medicine Lewis Katz School of Medicine Temple University School of Medicine Chair, Department of Thoracic Medicine & Surgery Co-Director Center for Inflammation and Lung Research Medical Director of Pulmonary Service Line Temple University Hospital Philadelphia, PA CONTRIBUTING FACULTY Roberto Rodriguez-Roisin, MD, PhD Professor Emeritus of Medicine Universitat de Barcelona Department of Pulmonary Diseases Hospital Clinic Vilarroel Barcelona, Spain Claus Vogelmeier, MD Professor of Internal Medicine Head of Pulmonary and Critical Care Medicine University Medical Center Giessen and Marburg Philipps-University Marburg Germany School of Medicine Marburg, Germany Nicolas Roche, MD, PhD Professor of Respiratory Medicine, Respiratory and Intensive Care Medicine Cochin-Hôtel-Dieu-Broca Hospital Group University of Paris Descartes Assistance Publique- Hôpitaux Paris, France Fernando Martinez, MD Executive Vice Chair of Medicine Gladys and Roland Harriman Professor of Medicine Joan and Sanford I. Weill Cornell Medical College New York-Presbyterian Hospital/Weill Cornell Medical Center New York, NY Antonio R. Anzueto, MD Chief 0f Pulmonary Section Medical Director of Pulmonary Function Laboratory, Respiratory Therapy Department and Bronchoscopy Laboratory Director of Pulmonary Function Laboratory and Pulmonary Service Spinal Cord Unit Staff Physician, South Texas Veterans Health Care System Audie L. Murphy Memorial Veterans Hospital Division Director of Pulmonary Function Laboratory University Hospital Adjunct Scientist, Southwest Foundation for Biomedical Research Professor, University of Texas Health Science Center San Antonio Department of Medicine San Antonio, TX David Michael George Halpin, MD Consultant Physician Royal Devon & Exeter Hospital Honorary Associate Professor University of Exeter Medical School Devon, United Kingdom Maria Victorina López Varela, MD Chair, GOLD Dissemination Committee Professor Agregado de Neumología Universidad de la República Montevideo, Uruguay Alvar Agustí, MD, PhD Associate Professor of Medicine University of Barcelona Director, Thorax Institute, Hospital Clinic Barcelona, Spain Educational Activity Agenda Comorbidities in COPD Front Matter and Registration (3 minutes) Faculty Introduction, Presentations and Roundtable Discussions (54 minutes) Post Test, Evaluation, and Credit Application (10 minutes) Release and Expiration Dates Enduring Archive Release Date: June 15, 2017 Enduring Archive Expiration Date: June 15, 2018 Disclosure of Conflicts of Interests Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Disclosure information will be provided to participants prior to the beginning of the educational activity. Faculty Disclosures The *faculty* reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: Gerard J. Criner, MD Grant/Research Support: NIH-NHLBI, PA-DOH,GSK, Boehringer- Ingelheim, Novartis, Astra Zeneca, Respironics, MedImmune, Actelion, Forest, Pharmaxis, Pearl, Ikaria, Aeris, PneumRx, Pulmonx Honoraria: None Consultation: Amirall, Holaira, Boehringer-Ingelheim, GSK, Pearl, Astra Zeneca, PneumRX Equity Interest: HGE Health Care Solutions, Inc. Roberto Rodriquez-Roisin, MD Consultant: AstraZeneca, Boehringer Ingelheim, Ferrer, Menarini, Novartis, Pearl, Takeda and TEVA Grant/Research Support: Almirall and Menarini Claus Vogelmeier, MD Grant/Consultant Support: AstraZeneca, CSL Behring, Berlin Chemie/Menarini, Boehringer Ingelheim, Cipla, GlaxoSmithKline, Grifols, MedUpdate, Mundipharma, Novartis, OmniaMed Nicolas Roche, MD Grant/Consultant Support: 3M, Almirall/AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Zambon, Mundipharma, Novartis, Nycomed/Takeda, Pfizer, Sandoz, Sanofi and Teva Fernando Martinez, MD Grant/Consultant Support: Adept, Academic CME, Afferent, American College of Chest Physicians, AstraZeneca, Bayer, Boehringer Ingelheim, Concert, Genentech, Gilead, GlaxoSmithKline, Integritas, Medical Leverage, Mereo, Methodist Hospital, Miller Medical, Novartis, PeerView, PlatformIQ, Potomac, Prime, ProterixBio, Stromedix/Biogen, Theravance, UpToDate, Veracyte, WebMD/MedScape, Western Connecticut Health Network Antonia R. Anzueto, MD Consultant: AstraZeneca, Novartis, Boehringer-Ingelheim, GSK, Sunovion David Halpin, MD Grant/Consultant Support: Almirall/AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Pfizer, Sandoz Maria Victorina Lopez Varela, MD Consultant: Astra Zeneca, Boehringer Ingelheim, Glaxo SmithKlein, Novartis. Alvar Agusti, MD, PhD Nothing to Disclose Planners and Managers The *planners and managers* reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: GLOBAL EDUCATION GROUP / GANESCO, INC. Ashley Marostica, RN, MSN Nothing to disclose Kristen Delisi Nothing to disclose Lindsay Borvansky Nothing to disclose Laura Gilsdorf Nothing to disclose Gail Varcelotti, BS, RRT, FAARC, Ganesco, Inc. Nothing to disclose Nancy Nunley, BS, MBA, Ganésco, Inc Nothing to disclose CME Provided Accreditation Statement This activity is provided by Global Education Group. Physician Accreditation Statement - CME Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database. Physician Credit Designation - CME Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Global Education Group For information about the physician accreditation for this activity, please contact Global Education Group at (303) 395-1782, or inquire@globaleducationgroup.com. How to Obtain CME Credit Attendees are expected to view the entire activity before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit™* or nursing credit. To receive credit, the course must be completed between June 15, 2017 and June 15, 2018. Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive CME/CE credit for viewing the webcast: Read all of the CME/CE accreditation information above. View the complete electronic (web) activity. Click on the link to apply for CME/CE credits. Complete the online registration (registration is free). Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate. After successfully completing the online test and/or evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity. Should you have any CME/CE questions regarding this activity, please contact: Global Education Group 5575 S. Sycamore Street, Suite 200 Littleton, CO 80120 Phone: 303-395-1782 Fax: 303-648-5311 Email: inquire@globaleducationgroup.com Web: www.globaleducationgroup.com Click here to view this activity Fee Information There is no fee for this educational activity. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Policy on Privacy and Confidentiality Global Education Group (Global) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency. Global Education Group and Dane Garvin, Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. Medium Used This program has been made available online. “Comorbidities in COPD” System Requirements To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled. Nearly all modern web browsers will work. Commercial Support Statement This online Resource Center is supported by Educational Grants from AstraZeneca, GlaxoSmithKline, Boehringer Ingleheim, BTG International Inc. and PneumRx. Copyright Copyright^©2017 Global Initiative for Chronic Obstructive Lung Disease. All Rights Reserved. Permission for accreditation use granted to Global Education Group (Global). Web interface provided by Dane Garvin Ltd.

Resource Center Title